Skip to content
Screener

Kodiak Sciences Inc KOD Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

EyePoint, Inc. logo
EyePoint, Inc.EYPT
$9.37M+58.9%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$19.56M+444%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
KLR
Kalaris TherapeuticsKLRS
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
Bausch + Lomb logo
Bausch + LombBLCO

Other financials

Income statement

See full
Operating income-$59.8M-1.2%
Net income-$58.2M-1.2%
EPS (diluted)-$0.94+13.8%

Balance sheet

See full
Cash & equivalents$169.5M+22.1%
Total debt$56.0M-17.2%
Total equity$112.1M+3.0%
Total assets$306.0M+2.7%

Cash flow

See full
Operating cash flow-$40.0M-37.6%
CapEx$942.0K+249%
Free cash flow-$41.0M-39.5%

Valuation

See full
Market cap$2.84B+541%
Enterprise value$2.73B+576%

Returns & leverage

See full
Return on equity-208.8%+2,306pp
Debt / equity0.5×-0.1×
Current ratio3.5×-1.1×

Where this comes from

Reported directly by Kodiak Sciences Inc in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: Kodiak Sciences Inc’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-211951
Line itemMarch 31,2026December 31,2025
Restricted cash6,1846,184
Property and equipment, net81,51285,258
Operating lease right-of-use asset34,37536,606
Other assets8,6778,669
Total assets$306,006$351,533
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable$11,344$12,863

Item 1. Financial Statements (Unaudited).

FAQ

What is Kodiak Sciences Inc's deferred tax assets and other non-current assets?
Kodiak Sciences Inc (KOD) reported deferred tax assets and other non-current assets of $8.68M in Q1 2026.
How has Kodiak Sciences Inc's deferred tax assets and other non-current assets changed year-over-year?
Kodiak Sciences Inc's deferred tax assets and other non-current assets increased by 0.2% year-over-year, from $8.66M to $8.68M.
What is the long-term trend for Kodiak Sciences Inc's deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), Kodiak Sciences Inc's deferred tax assets and other non-current assets has grown at a -3.2% compound annual growth rate (CAGR), from $10.21M to $8.67M.

Ask your AI about Kodiak Sciences Inc's deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude